Molecular Mechanism of Caffeine-Aspirin Interaction in Kopi Balur 1 as Anti-Inflammatory Agent: A Computational Study
Keywords:Anti-inflammatory agent, computational study, kopi balur 1, molecular mechanism.
Balur treatment (BT) is a method that works to remove toxins in the form of free radicals released via the
skin. One of the remedies used is Kopi Balur 1 (KB1) which contains aspirin and caffeine used during
the BT, so that KB1 is believed to have the potential to reduce or inhibit the occurrence of inflammatory
processes in the body. Therefore, we investigate the interactions that occur between ligands and proteins,
predict the action mode of caffeine-aspirin contained in KB1 as an anti-inflammatory agent, and modeling
the 3D structure of pro-inflammatory proteins in the human body. The target compound, aspirin-caffein,
was obtained from a database, then used to identify the pathway on the STITCH webserver, then the target
protein was obtained and modeled in 3D using the SWISS-MODEL webserver, and the structures obtained
were represented in PyMol software. In sum, the aspirin-caffeine ligand complex contained in KB1 has the
potential as an anti-inflammatory agent in the human body via the molecular mechanism of binding and
inhibiting the biological activity of proinflammatory proteins, i.e. PTGS1, PTGS2, and ADOR2A.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions